Response to “comment on CSF and plasma GFAP and VEGF in adult type 3 spinal muscular atrophy patients treated with nusinersen”

Journal of the Neurological Sciences 2026

View at publisher

Authors: Ana Catarina Pronto‐Laborinho, M. Viseu De Carvalho, Miguel Oliveira Santos

DOI: 10.1016/j.jns.2026.125856

Cited by: 0

References: 3

Fields of Study & Subjects

Neurogenetic and Muscular Disorders Research Amyotrophic Lateral Sclerosis Research Lysosomal Storage Disorders Research

References 3